1.2 Patient History, Clinical Assessment & Neurological Evaluation
Key Takeaways
- A structured pre-study intake requires extracting past routine EEG findings, high-resolution neuroimaging data (3T MRI epilepsy protocol, 18F-FDG PET, SISCOM), and baseline neurological deficits before initiating LTM.
- Anti-seizure medication (ASM) review must document exact dosing, serum levels, pharmacokinetics (half-lives, hepatic vs. renal clearance), and adherence to safely anticipate withdrawal seizure kinetics.
- Detailed semiology diaries identifying aura types, initial motor evolutions, and post-ictal patterns dictate tailored electrode placements and customized ictal testing protocols.
- Age-specific physiological considerations guide monitoring strategy: electroclinical dissociation and discontinuous backgrounds in neonates, syndrome-specific patterns in children, and atypical non-convulsive presentations with fragile skin integrity in the elderly.
- Pre-existing craniotomy defects produce 'breach rhythm'—focal high-amplitude sharp beta and mu activity—which must be differentiated from true pathological epileptiform discharges.
1.2 Patient History, Clinical Assessment & Neurological Evaluation
The diagnostic yield, patient safety, and technical quality of long-term video-EEG monitoring (LTM) depend directly on the rigor of the pre-study clinical assessment. Before applying a single electrode or configuring recording montages, the neurodiagnostic technologist must systematically extract and analyze the patient's medical history, prior diagnostic workups, pharmacological profile, and baseline neurological status. This clinical intelligence enables the technologist to formulate customized recording strategies, anticipate seizure kinetics, deploy targeted behavioral testing, and mitigate clinical emergencies.
1. Medical Record Extraction & Workup Synthesis
A structured review of electronic medical records (EMR) establishes the baseline electrophysiological and anatomical landscape of the patient's condition.
+-----------------------------------------------------------------------------+
| PRE-STUDY CLINICAL DATA SYNTHESIS PIPELINE |
| |
| [1] PRIOR EEG ARCHIVE REVIEW |
| - Baseline Posterior Dominant Rhythm (PDR frequency, symmetry) |
| - Interictal Epileptiform Discharges (IED morphology, field, rate) |
| - Focal polymorphic slowing (delta/theta) vs. generalized slowing |
| - Previous activation yields (HV buildup, photoparoxysmal responses) |
| |
| [2] HIGH-RESOLUTION STRUCTURAL NEUROIMAGING |
| - 3T Dedicated Epilepsy Protocol MRI |
| - T1 3D volumetric, coronal oblique T2/FLAIR perpendicular to hippoc. |
| - Target Lesions: Mesial Temporal Sclerosis, FCD, DNET, Cavernomas |
| |
| [3] METABOLIC & FUNCTIONAL IMAGING |
| - 18F-FDG PET: Interictal glucose hypometabolism |
| - Ictal/Interictal SPECT (SISCOM): Hyperperfusion coregistered to MRI |
| - Functional MRI (fMRI) / WADA: Language and memory lateralization |
| |
| [4] BASELINE NEUROLOGICAL & COMORBIDITY PROFILE |
| - Pre-existing motor deficits (hemiparesis), visual field cuts |
| - Craniotomy bone flaps (Breach rhythm identification) |
| - Cardiorespiratory status (arrhythmias, pacemaker, sleep apnea) |
+-----------------------------------------------------------------------------+
Review of Prior Routine and Video-EEGs
The technologist must review all available historical EEG reports and raw tracings:
- Background Organization: Document the frequency, amplitude, and reactivity of the posterior dominant rhythm (PDR). A unilateral slowing or absence of the PDR suggests structural or functional dysfunction of the ipsilateral hemisphere.
- Interictal Epileptiform Discharges (IEDs): Note the exact anatomical distribution, polarity, and firing rate of spikes, sharp waves, and polyspikes. Differentiate between unilateral temporal spikes (e.g., anterior temporal F7/T3 maximum), multifocal spikes, and generalized bilateral synchronous spike-and-wave discharges.
- Rhythmic Slowing Patterns: Identify patterns such as Temporal Intermittent Rhythmic Delta Activity (TIRDA)—a highly specific electrographic marker for temporal lobe epilepsy—or Frontal Intermittent Rhythmic Delta Activity (FIRDA), which often reflects non-specific diffuse encephalopathy or subcortical dysfunction.
High-Resolution Structural & Functional Neuroimaging
Understanding the patient's imaging findings directly informs electrode montage selection and clinical surveillance:
- 3T Epilepsy Protocol MRI: Standard clinical MRI scans often miss subtle epileptogenic structural lesions. High-resolution epilepsy protocols utilize thin-slice (1 mm) volumetric 3D T1-weighted sequences, high-resolution coronal oblique T2-weighted and Fluid-Attenuated Inversion Recovery (FLAIR) sequences oriented perpendicular to the long axis of the hippocampus, and susceptibility-weighted imaging (SWI). Major target pathologies include:
- Mesial Temporal Sclerosis (MTS) / Hippocampal Sclerosis (HS): Characterized by hippocampal atrophy on T1 and hyperintensity on T2/FLAIR, associated with intractable temporal lobe epilepsy.
- Focal Cortical Dysplasia (FCD): Developmental malformations of cortical development (Type I, IIa, IIb) showing cortical thickening, blurring of the gray-white matter junction, and the "transmantle sign" (T2/FLAIR hyperintense band extending from the cortex to the ventricle).
- Developmental Tumors: Dysembryoplastic neuroepithelial tumors (DNET) and gangliogliomas.
- Vascular Malformations: Cavernous angiomas (cavernomas) showing a characteristic "popcorn" appearance with a hemosiderin ring on SWI/T2*.
- 18F-FDG Positron Emission Tomography (PET): Measures interictal cerebral glucose metabolism. Epileptogenic zones typically demonstrate localized interictal glucose hypometabolism due to reduced baseline synaptic activity.
- Single-Photon Emission Computed Tomography (SPECT) & SISCOM: Ictal SPECT requires the technologist or nurse to inject a radiotracer (e.g., 99mTc-HMPAO) at the immediate onset of an electroclinical seizure. The tracer locks into cerebral tissue during the first pass, capturing the regional hyperperfusion of the ictal onset zone. Subtraction Ictal SPECT Co-registered to MRI (SISCOM) digitally subtracts interictal from ictal scans and overlays the hyperperfused focus onto the patient's 3T MRI.
2. Anti-Seizure Medication (ASM) Profiling & Pharmacokinetics
Careful evaluation of the patient's anti-seizure medication history is essential for anticipating seizure withdrawal kinetics, recognizing medication toxicity, and maintaining patient safety during planned medication reductions.
+-----------------------------------------------------------------------------+
| ANTI-SEIZURE MEDICATION (ASM) MATRIX |
| |
| MEDICATION HALF-LIFE (t1/2) METABOLISM / CLEARANCE EMU TAPERING |
| -------------- ----------------- ----------------------- ------------ |
| Levetiracetam 6 - 8 hours 66% Renal unchanged Rapid wash-out|
| (Keppra) Enzymatic hydrolysis (1-2 days) |
| |
| Lacosamide 13 hours Renal / Hepatic (CYP2C19)Moderate taper|
| (Vimpat) (2-3 days) |
| |
| Carbamazepine 12 - 17 hours Hepatic (CYP3A4 auto- Moderate taper|
| (Tegretol) (auto-induced) induction) Rebound risk |
| |
| Lamotrigine 24 - 35 hours Hepatic glucuronidation Slow wash-out |
| (Lamictal) (monotherapy) (altered by VPA/inducers)(3-4 days) |
| |
| Valproic Acid 9 - 18 hours Hepatic (inhibits UGT & Moderate taper|
| (Depakote) CYP enzymes) Tremor/tox |
| |
| Clobazam 18 - 42 hours Hepatic (CYP3A4/CYP2C19) Severe with- |
| (Onfi) (Active metabolite active metabolite t1/2: drawal status |
| N-desmethyl: 70h) 70 - 100 hours risk! Taper |
| very slowly! |
| |
| Phenobarbital 75 - 120 hours Hepatic (CYP2C9/2C19) Very slow; |
| Renal excretion high rebound |
+-----------------------------------------------------------------------------+
Pharmacokinetic Principles in the EMU
- Half-Life (t1/2): The time required for the plasma drug concentration to decrease by 50%. It takes approximately 4 to 5 half-lives for a drug to be almost completely eliminated from the body (washout).
- Enzyme-Inducing vs. Inhibiting ASMs: Medications such as carbamazepine, phenytoin, and phenobarbital induce hepatic cytochrome P450 enzymes, accelerating the clearance of co-administered drugs. Conversely, valproic acid inhibits glucuronidation, doubling the half-life of lamotrigine (increasing the risk of toxic epidermal necrolysis / Stevens-Johnson syndrome if lamotrigine is escalated rapidly).
- High-Risk Withdrawal Drugs: Abrupt discontinuation of benzodiazepines (e.g., clobazam, clonazepam, lorazepam) or barbiturates (e.g., phenobarbital, primidone) can trigger catastrophic rebound status epilepticus, severe autonomic instability, and delirium tremens-like withdrawal syndromes. These agents must be tapered with extreme caution under strict physician orders.
3. Seizure Semiology Diary & Behavioral Phenotyping
Taking a granular clinical history directly from the patient and family is vital for designing the study. The technologist should systematically interview the patient to map out their chronological semiological sequence.
+-----------------------------------------------------------------------------+
| SEIZURE SEMIOLOGY INTAKE & LOCALIZING CLUES |
| |
| [1] AURA (INITIAL SUBJECTIVE SENSATION) |
| - Epigastric rising sensation, nausea ------> Mesial Temporal (Amygd.)|
| - Olfactory / Gustatory hallucinations -----> Mesial Temporal / Uncus |
| - Experiential (Déjà vu, Jamais vu) --------> Temporal Neocortex/Mes. |
| - Formed visual hallucinations -------------> Temporal-Occipital |
| - Flashing lights, scotomas, colors --------> Primary Occipital Cortex|
| - Somatosensory tingling, numbness ---------> Primary Sensory Cortex |
| |
| [2] EARLY MOTOR & BEHAVIORAL MANIFESTATIONS |
| - Behavioral arrest with stare, lip smacking -> Mesial Temporal |
| - Unilateral manual automatisms -------------> Ipsilateral Hemisphere |
| - Unilateral dystonic limb posturing --------> Contralateral Basal G. |
| - Asymmetric tonic posturing ("Figure-4") ---> Extended arm = Contralat|
| - Head/Eye deviation (forced versive) -------> Contralateral Frontal |
| - Bicycling / Pelvic thrusting (Hypermotor) -> Frontal Lobe / Cingulate|
| |
| [3] POST-ICTAL DEFICITS & LATERALIZING PHENOMENA |
| - Todd's hemiparesis (motor weakness) ------> Contralateral Hemisphere|
| - Post-ictal aphasia / paraphasic errors ---> Dominant Hemisphere |
| - Post-ictal nose wiping (unilateral hand) -> Ipsilateral Hemisphere |
| - Post-ictal coughing / vomiting -----------> Temporal Lobe |
+-----------------------------------------------------------------------------+
4. Age-Specific Physiological Considerations
Clinical evaluation and monitoring protocols vary widely across the lifespan:
+-----------------------------------------------------------------------------+
| AGE-SPECIFIC MONITORING CONSIDERATIONS |
| |
| AGE GROUP PHYSIOLOGICAL FEATURES TECHNICAL & CLINICAL FOCUS |
| --------------- -------------------------- --------------------------- |
| NEONATAL - Discontinuous background - Synchronized polygraphy |
| (0 - 28 days) (trace alternant/discont.) (respiration, EOG, EMG, ECG)|
| - High rate of subclinical - Extra gentle skin prep; |
| electrographic seizures hydrogel/paste over collo. |
| |
| PEDIATRIC - Syndrome-specific spikes - Behavioral observation and |
| (Infant - Child) (hypsarrhythmia, CSWS, caregiver involvement |
| 3 Hz spike-wave, rolandic)- Sleep deprivation protocols|
| - High frequency of arousals- Fall pads / crib safety |
| |
| GERIATRIC - Slowed background alpha - Pressure injury prevention |
| (Elderly >65y) - Atypical NCSE / delirium - Strict fall precautions |
| - High vascular comorbidity - Fragile skin / non-collodion|
+-----------------------------------------------------------------------------+
Neonatal Considerations
Neonates frequently exhibit electroclinical dissociation, where profound electrographic seizures occur without observable clinical movement, or where motor movements (such as bicycling or sucking) occur without cortical ictal discharges. Continuous synchronized polygraphy (respiration, eye movements, EMG, ECG) is mandatory.
Pediatric Considerations
Children frequently manifest specific electro-clinical syndromes such as Infantile Epileptic Spasms Syndrome (hypsarrhythmia pattern), Childhood Absence Epilepsy (generalized 3 Hz spike-wave provoked by hyperventilation), and Developmental and Epileptic Encephalopathy with Spike-Wave Activation in Sleep (DEE-SWAS / CSWS) where epileptiform activity occupies >85% of NREM sleep.
Geriatric Considerations
Elderly patients presenting with new-onset seizures often have subtle, non-convulsive semiologies (e.g., transient confusion, wandering, fluctuating responsiveness). Because aging skin possesses a fragile epidermis, prolonged collodion or abrasive applications can cause skin tears; frequent skin integrity checks (every 12 to 24 hours) and foam padding are mandatory.
5. Identifying Breach Rhythm & Skull Defects
When a patient has undergone a previous craniotomy, burr hole placement, or traumatic skull fracture, the normal high-frequency electrical filtering and attenuation provided by the intact calvarium is lost.
+-----------------------------------------------------------------------------+
| THE BREACH RHYTHM PHENOMENON |
| |
| INTACT SKULL (High Resistance & Capacitance) |
| [Cortex] ===> [CSF] ===> [BONE / SKULL (Filters Beta/Spikes)] ===> [Scalp]|
| Result: Filtered, smoothed, attenuated surface voltage. |
| |
| BONE FLAP DEFECT / CRANIOTOMY (Breach Effect) |
| [Cortex] ===> [CSF] ========================================> [Scalp] |
| Result: Focal high-voltage, sharply contoured, spiky beta/mu activity. |
| NO after-going slow wave. NO spatial propagation. |
+-----------------------------------------------------------------------------+
Key Characteristics of Breach Rhythm
- Morphology: Unusually high-amplitude (often 100 to 200+ µV), sharply contoured, rhythmic activity in the beta (18-25 Hz), alpha, or mu (9-11 Hz) frequency ranges directly overlying the skull defect.
- Differentiation from Epileptiform Discharges: True epileptiform spikes typically have a physiological field of distribution, an asymmetrical rising and falling phase, and a prominent following slow wave. In contrast, breach activity lacks an after-going slow wave, remains localized strictly to electrodes over the bone defect, and does not demonstrate dynamic electrographic evolution.
6. Clinical Worked Scenario & Traps
+-----------------------------------------------------------------------------+
| CLINICAL CASE: DISCORDANT WORKUP SYNTHESIS |
| |
| PATIENT: 30-year-old female with drug-resistant focal epilepsy (4 yrs). |
| PRE-STUDY INTAKE: |
| - Prior Routine EEG: Frequent left anterior temporal sharp waves (F7-T3). |
| - 3T MRI Brain: Normal gray-white differentiation; no MTS or FCD. |
| - 18F-FDG PET: Left temporal hypometabolism extending to frontal operculum|
| - Semiology Diary: Epigastric aura -> vocal arrest -> right hand dystonic |
| posturing and left hand manual automatisms -> post-ictal dysphasia. |
| |
| LTM STRATEGY DECISION: |
| - Place expanded 10-10 montage + true Silverman T1/T2 inferior temporal |
| leads to maximize mesial temporal and frontotemporal spatial coverage. |
| - Prepare for ictal SPECT tracer injection at earliest clinical onset. |
| - Result: Captured 4 seizures showing left mesial temporal onset (T1/FT9) |
| with SISCOM hyperperfusion in left hippocampus -> cleared for Phase II. |
+-----------------------------------------------------------------------------+
[!CAUTION] Critical Clinical Traps:
- Trap 1: Overlooking Valproate-Lamotrigine Co-administration: Rapidly discontinuing valproate can plunge lamotrigine serum levels, while re-introducing valproate quickly can trigger toxic lamotrigine levels and Stevens-Johnson syndrome.
- Trap 2: Ignoring Subtle Ictal Asystole: In mesial temporal lobe seizures, autonomic central network disruption can produce severe bradycardia or sinus arrest. Continuous ECG channel surveillance is mandatory to detect ictal asystole exceeding 3 to 4 seconds.
A 45-year-old patient who underwent a left frontotemporal craniotomy for evacuation of a subdural hematoma two years ago is admitted to the EMU. The baseline EEG demonstrates focal, sharply contoured, high-voltage 18 to 24 Hz beta activity over F3, F7, and C3 without an after-going slow wave, which remains unchanged in frequency and spatial distribution during waking and drowsiness. What is the most accurate clinical interpretation of this finding?
An epileptologist reviews the presurgical workup of a 30-year-old patient with drug-resistant temporal lobe epilepsy. Which neuroimaging modality is specifically designed to measure interictal cerebral glucose metabolism, characteristically demonstrating regional hypometabolism in the epileptogenic zone?
A patient with refractory focal epilepsy is admitted to the EMU for elective anti-seizure medication (ASM) tapering. The patient's daily medication regimen includes Levetiracetam (Keppra), Lacosamide (Vimpat), and Clobazam (Onfi). Which pharmacological property of Clobazam requires the most cautious and gradual withdrawal strategy?
While monitoring a 38-year-old patient with left mesial temporal lobe epilepsy in the EMU, the technologist observes a habitual focal impaired awareness seizure on video. On the time-locked single-lead ECG channel, the heart rate drops progressively from 78 bpm to marked sinus bradycardia, followed by a 7-second period of complete ventricular asystole. What is the correct clinical interpretation and immediate priority?